Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 70 companies in Commodity Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
Cash ₹0 cr vs borrowings ₹13 cr (FY26): borrowings are higher by ₹13 cr.
No promoter shares are pledged.
Operating cash flow was below net profit in 0 of the last 5 years.
Net loss in 8 of the last 8 quarters.
No dividend in the last 5 financial years.
Price ₹8.58 on 2026-10-26: -61.1% from the 52-week high, +7.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹40.16 · low ₹8.58
RevenueNet profit
RevenueNet profit
Quarterly results
₹ cr
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
0
0
0
0
0
0
0
0
EBITDA
-0
-0
-0
-0
-0
-0
-0
-0
OPM %
–
–
–
–
–
–
–
–
Other income
0
0
0
0
0
0
0
0
Net profit
-0
-0
-0
-0
-0
-0
-0
-0
EPS (₹)
-0.04
-0.03
-0.05
0.04
-0.06
-0.04
-0.09
-0.11
Revenue YoY
–
–
–
–
Profit YoY
–
–
–
–
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
₹ cr
FY22
FY23
FY24
FY25
FY26
TTM
Revenue
0
0
0
0
0
0
EBITDA
-0
-1
-0
-0
-0
-1
Net profit
-0
-1
-0
-0
-0
-1
EPS (₹)
-0.20
-0.74
-0.22
-0.20
-0.22
-0.30
Revenue growth
–
–
–
–
–
Profit growth
–
–
–
–
–
Dividend / share (₹)
–
–
–
–
–
Compounded growth
3 years
5 years
Last 12 months
Sales
–
–
–
Net profit
–
–
–
EPS
–
–
–
Share price
–
-38.2% (2y)
-50.1%
Balance sheet
₹ cr
FY22
FY23
FY24
FY25
FY26
Shareholders' equity
–
-17
-18
-18
-19
Borrowings
–
13
13
13
13
Cash & equivalents
–
0
0
0
0
Total assets
–
6
5
4
4
Fixed assets
–
4
3
3
3
Capital work in progress
–
0
0
0
0
Investments
–
0
0
0
0
Receivables
–
0
0
0
0
Inventory
–
0
0
0
0
Payables
–
0
0
0
0
Year-end figures from the March annual filing.
Cash flow
₹ cr
FY22
FY23
FY24
FY25
FY26
Cash from operations
-0
-1
-0
1
-0
Cash from investing
0
0
0
0
0
Cash from financing
0
1
0
-1
0
Capex
0
0
0
0
0
Free cash flow
-0
-1
-0
1
-0
Free cash flow = cash from operations − capex.
Ratios by year
₹ cr
FY22
FY23
FY24
FY25
FY26
ROE %
–
8.0%
2.3%
2.1%
2.3%
ROCE %
–
31.0%
9.0%
6.8%
7.4%
Shareholding
Holder
% (2026-09-30)
Promoters
47.71%
DIIs
1.42%
of which Mutual funds
0.06%
of which Insurance
0.29%
Government
2.30%
Public (non-institutions)
48.57%
Quarter
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters %
47.71%
47.71%
47.71%
47.71%
47.71%
47.71%
47.71%
47.71%
Promoter group
%
Varghese Kurian
46.48%
Lizhyamma Kurian
0.89%
Jeeben Varghese Kurian
0.34%
Aradhana Somani
0.00%
Shreeniwas Somani
0.00%
Shantadevi Somani
0.00%
Shrikant Shreeniwas Somani
0.00%
Chemo Pharma Laboratories Ltd
0.00%
Citric India Limited
0.00%
India Ener-gen Private Ltd Formerly Tecil Finance Ltd
0.00%
Public holders above 1%
%
Kerala State Industrial Development
1.56%
Shaji K Mathew
1.07%
Kanta Chowdhary
1.01%
24,352 shareholders. Pledged: 0.00% of promoter shares.
Links go to the original files on the exchange website.
About the company
Sector
Commodities
Industry
Commodity Chemicals
Sub-industry
Commodity Chemicals
Symbol
TECILCHEM
BSE code
506680
ISIN
INE014B01011
Face value
₹10.0
Incorporated
–
Website
–
Plants (India / abroad)
–
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.